| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $572.5M | $504.2M | $404.1M |
| YoY Revenue Growth % | +13.6% | +24.8% | — |
| Gross Profit | $53.1M | $46.3M | — |
| Gross Margin % | 9.3% | 9.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $16.9M | $14.7M | $13.9M |
| Operating Margin % | 2.9% | 2.9% | 3.4% |
| Net Income (GAAP) | $11.9M | $10.9M | $10.3M |
| EBITDA (Normalized) | $32.1M | $38.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $16.1M | $15.0M | $14.1M |
| Capital Expenditures (CapEx) | $19.0M | $29.5M | — |
| Free Cash Flow (FCF) | -$2.9M | -$14.5M | $14.1M |
| FCF Margin % | -0.5% | -2.9% | 3.5% |
| Return on Invested Capital (ROIC %) | 10.2% | 11.7% | — |
| Cash & Short-Term Equivalents | $35.3M | $34.7M | — |
| Total Debt (Short + Long Term) | $33.8M | $16.4M | — |
| Total Stockholders' Equity | $131.9M | $117.1M | — |